C. Grossi

发表

Signaling through CD38 induces NK cell activation.

C. Tacchetti, F. Malavasi, G. Baj, 2001, International immunology.

Basic biomedical instrumentation for underwater human biotelemetry

A. L'Abbate, M. Passera, R. Bedini, 2014 .

Patients with antiphospholipid syndrome display endothelial perturbation.

D. Mari, L. Ghiadoni, L. Lonati, 2010, Journal of autoimmunity.

Reactivity against the Five Domains of β 2 Glycoprotein I: A Focus on Systemic Lupus Erythematosus

P. Meroni, M. Borghi, M. Gerosa, 2014 .

Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study.

P. Ravani, P. Messa, A. Tincani, 2016, Journal of autoimmunity.

Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study.

P. Ravani, P. Messa, A. Tincani, 2016, Journal of autoimmunity.

Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against β2‐Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti–Domain 1 to Anti–Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome

A. Tincani, M. Mahler, L. Andreoli, 2015, Arthritis & rheumatology.

Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome

D. Isenberg, P. Meroni, V. Ripoll, 2018, Journal of autoimmunity.

Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome

G. Parati, M. Muiesan, M. Salvetti, 2020, Frontiers in Immunology.

Complement activation and endothelial perturbation parallel COVID-19 severity and activity

A. Pesenti, G. Costantino, F. Blasi, 2020, Journal of Autoimmunity.

Prevalence, specificity, and clinical association of anti-phospholipid antibodies in COVID-19 patients: are the antibodies really guilty?

G. Parati, M. Muiesan, M. Salvetti, 2020, medRxiv.

Updating on the Pathogenic Mechanisms 5 of the Antiphospholipid Antibodies-Associated Pregnancy Loss

P. Meroni, M. Borghi, M. Gerosa, 2008, Clinical reviews in allergy & immunology.

β2-glycoprotein I, lipopolysaccharide and endothelial TLR4: three players in the two hit theory for anti-phospholipid-mediated thrombosis.

N. Ronda, P. Meroni, R. Gatti, 2014, Journal of autoimmunity.

A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome.

D. Sblattero, P. Meroni, Francesco Saverio Tedesco, 2014, Blood.

A non complement-fixing antibody to β 2 glycoprotein I as a novel therapy to control abortions and thrombosis in antiphospholipid syndrome

D. Sblattero, P. Meroni, Francesco Saverio Tedesco, 2014 .

Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome

P. Meroni, M. Borghi, P. Meroni, 2008, Lupus.

Fibrosis biomarkers in isolated Raynaud's phenomenon: too little, too soon?

P. Boracchi, F. Ingegnoli, W. Rosenberg, 2013, Annals of the rheumatic diseases.

Pathogenesis of the obstetric antiphospholipid syndrome: the key role of beta 2 glycoprotein I

F. Tedesco, C. Grossi, P. Meroni, 2022, Exploration of Immunology.

Chapter 4 Mechanisms of Action of Antiphospholipid Antibodies

P. Meroni, M. Borghi, C. Grossi, 2009 .

Obstetric and vascular APS: Same autoantibodies but different diseases?

L. Trespidi, P. Meroni, B. Acaia, 2012, Lupus.

Antiphospholipid Antibodies and the Antiphospholipid Syndrome: Pathogenic Mechanisms

Pojen P. Chen, P. Meroni, I. Palomo, 2008, Seminars in thrombosis and hemostasis.

In vivo distribution of (cid:1) 2 glycoprotein I under various pathophysiologic conditions

P. Meroni, A. Bek, Andrea Lorenzon, 2011 .

Role of anti-beta2 glycoprotein I antibodies in antiphospholipid syndrome: in vitro and in vivo studies.

N. Ronda, P. Meroni, M. Borghi, 2007, Clinical reviews in allergy & immunology.

Role of anti-β2 glycoprotein I antibodies in antiphospholipid syndromeglycoprotein I antibodies in antiphospholipid syndrome

N. Ronda, P. Meroni, M. Borghi, 2007 .

New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats

P. D. de Groot, M. Myers, P. Meroni, 2018, Haematologica.

Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cells

P. Meroni, C. Grossi, E. Raschi, 2014, Lupus.

Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?

P. Meroni, Francesco Saverio Tedesco, M. Borghi, 2018, Nature Reviews Rheumatology.

International standards for IgG and IgM anti-β2glycoprotein antibody measurement

I. Zegers, J. Sheldon, P. Meroni, 2014, Lupus.

Decreased salivary glucose secretory rate: usefulness for detection of diabetic patients with autonomic neuropathy.

P. Marchetti, A. Ciccarone, R. Giannarelli, 1989, Diabetes research and clinical practice.

Detection of red blood cell antibodies in mitogen‐stimulated cultures from patients with hereditary spherocytosis

A. Zanella, P. Bianchi, A. Cortelezzi, 2015, Transfusion.

In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions.

P. Meroni, A. Bek, Andrea Lorenzon, 2011, Blood.

Immune parameters identify Italian centenarians with a longer five-year survival independent of their health and functional status

C. Franceschi, C. Caruso, P. Sansoni, 2014, Experimental Gerontology.

Antiphospholipid Antibodies and Infertility: A Gene Expression Study in Decidual Stromal Cells.

Pojen P. Chen, P. Meroni, D. Gentilini, 2016, The Israel Medical Association journal : IMAJ.

Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss.

Pojen P. Chen, F. Ambrogi, P. Meroni, 2012, Journal of autoimmunity.

Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease

D. Nosi, M. Giovannini, C. Grossi, 2008, Neuroscience.

Complement Activation and Thrombin Generation by MBL Bound to β2-Glycoprotein I

P. Meroni, W. Planer, P. Garred, 2020, The Journal of Immunology.

conditions 2 glycoprotein I under various pathophysiologic β In vivo distribution of

P. Meroni, A. Bek, Francesco Saverio Tedesco, 2011 .

Beyond thrombosis: Anti-β2GPI domain 1 antibodies identify late pregnancy morbidity in anti-phospholipid syndrome.

A. Tincani, M. Mahler, L. Andreoli, 2018, Journal of autoimmunity.

Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers

M. Mahler, P. Schierack, P. Meroni, 2016, Arthritis Research & Therapy.

Anti-β2-glycoprotein I ELISA assay: The influence of different antigen preparations

P. Moerloose, G. Reber, A. Ruffatti, 2009, Thrombosis and Haemostasis.

Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value.

Y. Shoenfeld, M. Papp, M. Fritzler, 2023, Autoimmunity reviews.

Quality of life issues in patients with osteoporotic fractures

S. Minisola, C. Grossi, 2002, Aging clinical and experimental research.

Decreased sialylation of the acute phase protein α1-acid glycoprotein in feline infectious peritonitis (FIP)

F. Ceciliani, S. Paltrinieri, A. Giordano, 2004, Veterinary Immunology and Immunopathology.

Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome

M. D’Elios, C. Baldari, N. Maugeri, 2023, Frontiers in Immunology.

Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors.

P. Sarzi-Puttini, R. Caporali, P. Migliorini, 2020, Autoimmunity reviews.

Obstetric and vascular APS: Same autoantibodies but different diseases?

L. Trespidi, M. Borghi, C. Grossi, 2012, Lupus.